Syntheses of radioactive cyclols as potential precursors of the peptide moiety of ergot alkaloids
Gröger, D.; Syring, U.; Johne, S.
Die Pharmazie 30(7): 440-443
1975
ISSN/ISBN: 0031-7144 PMID: 1178758 Document Number: 88830
Document emailed within 1 workday
Related Documents
Robbers, J.E.; Jones, L.G.; Krupinski, V.M. 1974: Ergot physiology. the production of ergot alkaloids in saprophytic culture by a homokaryotic strain of ergot Lloydia 37(1): 108-111Schran, H.F.; Schwarz, H.J.; Talbot, K.C.; Loeffler, L.J. 1979: Specific radioimmunoassay of ergot peptide alkaloids in plasma Clinical Chemistry 25(11): 1928-1933
Floss, H.G.; Basmadjian, G.P.; Tcheng, M.; Gröger, D.; Erge, D. 1971: Biosynthesis of peptide-type ergot alkaloids. Ergocornine and ergocryptine Lloydia 34(4): 446-448
Mercier, C. 1982: Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics Journal de Pharmacie de Belgique 37(4): 289-298
Venn, R.D. 1976: Electroencephalogram and ergot alkaloids Postgraduate Medical Journal 52suppl. 1: 55-56
Walter, U. 1979: Risks of ergot alkaloids in obstetrics Medizinische Monatsschrift für Pharmazeuten 2(3): 76-80
Sterzl, J.; Rehácek, Z.; Cudlín, J. 1987: Regulation of the immune response by ergot alkaloids Czechoslovak Medicine 10(2): 90-98
Gorini, A.; Arnaboldi, R.; Vercesi, L.; Dossena, M. 1988: Influence of some ergot alkaloids on the cerebral reduced glutathione Il Farmaco; Edizione Scientifica 43(11): 887-890
Bernardi, L. 1979: From ergot alkaloids to nicergoline/Chemical points of view Arzneimittel-Forschung 29(8a): 1204-1206
Eich, E.; Pertz, H. 1994: Ergot alkaloids as lead structures for differential receptor systems Die Pharmazie 49(12): 867-877
Schmitt, H.; Fenard, S. 1970: Effects of ergot alkaloids on the vasomotor centers and their inhibition by clonidine Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 1006-1009
Vaupel, P.; Hutten, H. 1980: Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids Arzneimittel-Forschung 30(4): 598-602
Kozlovskiĭ, A.G.; Zhelifonova, V.P.; Antipova, T.V.; Zelenkova, N.F. 2011: Physiological and biochemical characteristics of fungi of the genus Penicillium as producers of ergot alkaloids and quinocitrinins Prikladnaia Biokhimiia i Mikrobiologiia 47(4): 469-473
Loew, D.M.; Depoortere, H.; Buerki, H.R. 1976: Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat Arzneimittel-Forschung 26(6): 1080-1083
Sarsúnová, M.; Semonský, M.; Cerný, A. 1970: Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography Journal of Chromatography 50(3): 442-446
Homewood, C.A.; Warhurst, D.C.; Baggaley, V.C. 1971: Incorporation of radioactive precursors into Plasmodium berghei in vitro Transactions of the Royal Society of Tropical Medicine and Hygiene 65(1): 10
Miragoli, G.; Ferrini, R. 1974: Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery Bollettino della Societa Italiana di Biologia Sperimentale 50(19): 1622-1628
Hoffman, W.; Rostock, A.; Siegemund, C.; Bartsch, R. 1989: AWD 52-39, an ergot derivative with potential nootropic activity Activitas Nervosa Superior 31(1): 56-57
Cazarré, E.A.; Barreto, T.M. 1974: Haemophilus ducreyi: various metabolic and morphological aspects studied by radioactive precursors and electron microscopy Revista do Instituto de Medicina Tropical de Sao Paulo 16(2): 95-102
Bernáth, G.; Fülöp, F.; Kóbor, J. 1993: Syntheses of potential drugs from 1-[bis(hydroxymethyl)methyl]-6,7-dialkoxy-1,2,3,4-tetrahydrois o- quinolines Acta Pharmaceutica Hungarica 63(3): 129-137